IBS and POTS: The Gut-Brain-Autonomic Connection Explained

If you have POTS and also struggle with irritable bowel syndrome — unpredictable bloating, cramping, diarrhea, constipation, or all of the above — you are not imagining a connection. Research consistently shows that IBS and POTS co-occur at rates far above chance, and the reason is mechanistic, not coincidental: both conditions are rooted in autonomic nervous system dysfunction.

How the Autonomic Nervous System Controls the Gut

The gastrointestinal tract is sometimes called the "second brain" because it contains the enteric nervous system (ENS), a network of approximately 500 million neurons embedded in the gut wall. The ENS governs peristalsis, secretion, and blood flow in the intestines largely independently — but it is continuously modulated by the autonomic nervous system (ANS).

The vagus nerve carries parasympathetic signals from the brainstem to the gut, promoting motility, enzyme secretion, and the "rest and digest" state. The sympathetic nervous system, when activated (as in standing up, stress, or a POTS episode), suppresses gut motility, redirects blood away from the intestines, and slows gastric emptying. In a healthy person, this balance shifts smoothly. In dysautonomia, it does not.

Why POTS Disrupts Gut Function

In POTS, the autonomic response to standing is dysregulated. Blood pools in the lower extremities, cardiac output drops, and the sympathetic nervous system fires compensatory signals to maintain blood pressure. These same sympathetic signals suppress gut motility, reduce mucosal blood flow, and alter intestinal secretion. The result is a gut that is chronically under-perfused and over-sympathetically driven — the physiological recipe for IBS.

Studies using gastric emptying scintigraphy have found that a significant proportion of POTS patients have delayed gastric emptying (gastroparesis) or accelerated small bowel transit, depending on their autonomic subtype. Hyperadrenergic POTS patients tend toward constipation-predominant patterns, while patients with low-flow neuropathic POTS more often experience diarrhea-predominant symptoms.

The Mast Cell Link

Many patients with POTS + IBS also have mast cell activation syndrome (MCAS), and this triad is increasingly recognized as a distinct clinical phenotype. Mast cells are concentrated in the gut wall and release histamine, prostaglandins, and other mediators that directly stimulate visceral pain receptors and alter motility. In MCAS, mast cell degranulation is triggered by foods, stress, hormonal shifts, and autonomic fluctuations — all of which are also POTS triggers. The result is a gut that is simultaneously dysautonomic and immunologically hyperreactive.

Shared Mechanisms with IBS

IBS is defined by the Rome IV criteria as recurrent abdominal pain associated with a change in stool frequency or form, without a structural cause. The pathophysiology of IBS includes visceral hypersensitivity (amplified pain signaling from the gut), altered gut motility, dysbiosis, and low-grade mucosal inflammation — all of which are worsened by autonomic dysfunction.

A 2020 study published in Neurogastroenterology & Motility found that patients with functional gastrointestinal disorders (including IBS) had significantly higher rates of orthostatic intolerance and heart rate variability abnormalities than healthy controls, suggesting that autonomic dysfunction is a shared upstream driver rather than a coincidental comorbidity.

Practical Implications for Treatment

Understanding the gut-autonomic connection changes how you approach treatment:

Treat the autonomic dysfunction first. Improving orthostatic tolerance — through increased sodium and fluid intake, compression garments, beta-blockers, or ivabradine — often improves gut symptoms as a downstream effect. Many POTS patients report that their IBS symptoms improve significantly when their heart rate is better controlled.

Address mast cell activation if present. A low-histamine diet, H1/H2 antihistamines, and mast cell stabilizers (cromolyn sodium, ketotifen) can dramatically reduce gut reactivity in patients with the POTS-MCAS-IBS triad.

Consider the low-FODMAP diet with caution. The low-FODMAP diet is the most evidence-based dietary intervention for IBS, but it is restrictive and can be difficult to implement alongside the high-sodium, high-fluid requirements of POTS management. Work with a dietitian who understands both conditions.

Vagal nerve stimulation and pacing. Because vagal tone is often reduced in POTS, interventions that enhance parasympathetic activity — slow diaphragmatic breathing, cold water immersion of the face, gentle aerobic exercise, and experimental vagal nerve stimulators — can improve both heart rate variability and gut motility simultaneously.

Probiotics and the gut microbiome. Dysbiosis (imbalanced gut bacteria) is common in both IBS and POTS, and emerging research suggests that the gut microbiome influences autonomic tone through the gut-brain axis. Lactobacillus rhamnosus GG and Bifidobacterium infantis have the strongest evidence base for IBS symptom reduction, though research in POTS-specific populations is limited.

Tracking the Connection

Because IBS symptoms in POTS are often triggered by the same things that trigger autonomic symptoms — standing, heat, eating large meals, stress, hormonal shifts — tracking them together is essential. Logging gut symptoms alongside heart rate, blood pressure, and activity in a health tracker can reveal patterns that are invisible when each symptom is tracked in isolation.

Key Takeaways

The IBS-POTS connection is not a coincidence. Both conditions share autonomic dysfunction as a root cause, and both are worsened by the same triggers. Treating the autonomic dysfunction often improves gut symptoms, and addressing gut inflammation and dysbiosis can reduce the inflammatory load that worsens autonomic instability. A comprehensive approach that treats both simultaneously — rather than managing them as separate conditions — gives the best outcomes.